KAUR, M., & MISRA, S. (2025). REMTERNETUG: AN INVESTIGATIONAL MONOCLONAL ANTIBODY AGAINST Β-AMYLOID FOR THE TREATMENT OF ALZHEIMER’S DISEASE (AD). International Journal of Current Pharmaceutical Research, 17(3), 7–9. https://doi.org/10.22159/ijcpr.2025v17i3.55038